Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Please provide your email address to receive an email when new articles are posted on . “Glaucoma medication is associated with changes in meibomian glands morphology, including decreased acinar area, ...

DED diagnosis rates are rising due to increased awareness and screen usage, affecting the tear film and causing symptoms like itching and blurred vision. Meibomian gland dysfunction is a primary cause ...

Please provide your email address to receive an email when new articles are posted on . The TearCare system has received 510(k) clearance from the FDA for the treatment of meibomian gland dysfunction, ...

PERTH, Australia – Sydney-based Azura Ophthalmics Ltd. has moved into a registration trial following positive phase II results for lead candidate AZR-MD-001 in Meibomian gland dysfunction, the leading ...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye ...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular ...

Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...

You’ve probably never heard of Meibomian Gland Dysfunction. But chances are, you may experience it at some point in your life. It’s something 69 News reporter Jaccii Farris knows firsthand. Over the ...

Label expansion for evaporative dry eye due to MGD will support further efforts to drive patient access to insurance-covered TearCare treatments MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- ...